Rating Change
Deutsche Bank analysts reiterated a Buy rating on DexCom, Inc. (NASDAQ:DXCM) on June 23, 2026.
reiterateNASDAQ:DXCM
Deutsche Bank Reiterates Buy Rating on DexCom, Inc. (DXCM)
Rating Change Deutsche Bank analysts reiterated a Buy rating on DexCom, Inc. (NASDAQ:DXCM) on June 23, 2026. Market Context DexCom, Inc.
Market Context
DexCom, Inc. operates in the Healthcare sector. The stock currently trades at $69.75 with a market capitalization of $27.0B. The stock has gained 1.1% over the past 52 weeks.
Analyst coverage from Deutsche Bank provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DexCom, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for DexCom, Inc.
Among the 10 most recent ratings: 9 Buy, 0 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 23, 2026 | Deutsche Bank | Buy | N/A |
| Jun 15, 2026 | Piper Sandler | Overweight | N/A |
| Jun 10, 2026 | TD Cowen | Buy | N/A |
| Jun 09, 2026 | Mizuho | Outperform | N/A |
| Jun 05, 2026 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View DXCM Stock Page
Frequently Asked Questions
What does a Buy rating mean for DXCM?
A Buy rating from Deutsche Bank reflects the analyst's outlook on DexCom, Inc. (NASDAQ:DXCM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DXCM forecast page.
